The Foxhall Research Unit currently has three active studies: 1. Injectable agent for severe psoriasis (closed to enrollment) 2. Oral medication for severe atopic dermatitis (open to enrollment) 3. Topical medication for contact dermatitis (open to enrollment) Please call 202-838-3016 if you would like more information regarding these studies.
My intention of this blog is to keep patients up-to-date on my clinical practice, research program, and current literature. This post will focus on advances in psoriasis. A recent study by Mease et al., found that one in eight subjects with psoriasis had a positive result on the screening test PEST for symptoms of psoriatic